A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis

Peer Review reports

Original Submission
22 Apr 2024	Submitted	Original manuscript
23 Aug 2024	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
23 Aug 2024	Editorially accepted
8 Sep 2024	Article published	10.1186/s13063-024-08425-x

Back to article page